We are monitoring the impact of COVID-19 on Europe NGS Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 94
Share on
Share on

Europe Next Generation Sequencing Market Research Report – Segmented By Product, Technology, Application and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2020 to 2025)

Pulished: February, 2020
ID: 94
Pages: 145

Europe Next Generation Sequencing Market Size (2020 to 2025)

The Europe NGS Market size is estimated to be USD 1.16 billion by the end of 2020 and is expected to reach USD 2.35 billion by 2025, showing a CAGR of 15.17% during the forecast period.

Next-generation sequencing has been commonly used in the medical field to determine the patient's genetic composition. For the necessary physical and genetic improvements, the use of NGS has also been used to modify plants and animals. NGS also enables biomarker discovery and genetic disease identification. Therefore, the NGS is used to produce precision medicine for the patient's genetic data to provide the person with personalized care.

Increased usage of personalized medicine, development in NGS bioinformatics and pre sequencing solutions and cloud computing, growth in population, increasing prevalence of infectious diseases, and chronic diseases such as cancer are few factors driving the market growth. Besides, anticipated decrease in the prices of genome sequencing due to the development of rapid, high capacity whole genome sequencers by key players is expected to show an optimistic effect on market penetration rates over the few years.

The extensive use of genomics for medical purposes has a significant effect in the years to come on the development of Europe's next-generation sequencing industry. Genomics consists of different technologies, like next-generation sequencing (NGS), genome editing, gene synthesis, and more.

European Next Generation Sequencing services industry driving factors are quicker and cost-effective sequencing, increasing NGS choice over all other platforms, and increasing hereditary disease prevalence. However, the use of genomics in drug development and discovery, the increasing incidence of cancer and other malignant diseases, and collaborations between businesses, Research & Development centers and universities complement production. The storage and management of data generated by sequencing and its interpretation, high reliability on grants & funding from the government and fall in capital expenditure from academic institutions are critical challenges for Europe's next-generation sequencing market.

This research report segmented and sub-segmented into the following categories:

  • By Product: Software and Services
  • By Technology: Targeted Re-Sequencing, Whole Genome Sequencing, De Novo Sequencing, Exome Sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq
  • By Application: Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture, and Animals Research
  • By Country: United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe

Regionally, Germany is expected to gain the largest market share in 2017 and maintain its position throughout the forecast period. Europe NGS Market is an increasing number of transfusion procedures that are expected to be the main drivers of market growth. The increase in complex procedures requiring large blood samples (chemotherapy, heart surgery, organ transplants, etc.) can also have a positive impact on the market and the low cost of screening is increasing the widespread use and spread of chronic infectious diseases, especially in developing countries. It is mainly used for the detection of HIV, HCV, and HBV and is recommended for routine use in Europe.

According to the World Health Organization, blood donations increased from 3.4% in 2008 to 3.6% in 2010. About 2 million people in Germany donate blood regularly. In France, NAT is voluntarily implemented to increase the safety of non-enveloped viruses such as the hepatitis A virus (HAV) and parvovirus B19 (B19V).

Leading companies in the Europe Next Generation Sequencing (NGS) Market are Illumina Incorporated, Thermo Fischer Scientific, Life Sciences (Roche), Pacific Biosciences, Life Technologies Corp. (Thermo Fischer Scientific), Macrogen Inc., Partek Inc., Genomatix Software GmbH, Perkin Elmer Inc., GATC Biotech AG, Agilent Technologies Inc., Biomatters Ltd., CLC Bio (Qiagen), BGI (Beijing Genomics Institute), Oxford Nanopore Technologies Ltd., Pacific Biosciences, DNASTAR Inc., Knome Inc., Illumina Inc., and Qiagen N.V.

  1. Introduction

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

  1. Research Methodology

                2.1 Introduction               

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

  1. Overview

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

  1. Market Segmentation

                5.1 By Product  

                                5.1.1 Software

                                5.1.2 Services

                5.2 By Technology           

                                5.2.1 Whole Targeted Re-Sequencing

                                5.2.2 Genome Sequencing

                                5.2.3 De Novo Sequencing

                                5.2.4 Exome Sequencing

                                5.2.5 RNA-Seq

                                5.2.6 ChIP-Seq

                                5.2.7 Methyl-Seq

                5.3 By Application           

                                5.3.1 Diagnostics

                                5.3.2 Drug Discovery

                                5.3.3 Biomarker Discovery

                                5.3.4 Personalized Medicine

                                5.3.5 Agriculture and Animals Research

  1. Geographical Analysis

                6.1 Introduction               

                6.2 U.K 

                6.3 Spain             

                6.4 Germany     

                6.5 Italy               

                6.6 France          

  1. Strategic Analysis

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

  1. Market Leaders' Analysis

                8.1 Macrogen Inc.           

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Thermo Fischer Scientific      

                8.3 Life Sciences (Roche)             

                8.4 Pacific Biosciences   

                8.5 Life Technologies Corp.         

                8.6 Partek Inc.  

                8.7 Genomatix Software GmbH

                8.8 Perkin Elmer Inc.      

                8.9 GATC Biotech Ag      

                8.10 Agilent Technologies Inc.   

                8.11 Biomatters Ltd.       

                8.12 CLC Bio (Qiagen)    

                8.13 Pacific Biosciences 

  1. Competitive Landscape

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

  1. Expert Opinions

                10.1 Market Outlook     

                10.2 Investment Opportunities 

     Appendix                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe NGS Market By Region, From 2020 to 2025 (USD Billion)
  2. Europe NGS Market By Product, From 2020 to 2025 (USD Billion)
  3. Europe Software Market By Region, From 2020 to 2025 (USD Billion)
  4. Europe Services Market By Region, From 2020 to 2025 (USD Billion)
  5. Europe NGS Market By Technology, From 2020 to 2025 (USD Billion)
  6. Europe Whole Targeted Re-Sequencing Market By Region, From 2020 to 2025 (USD Billion)
  7. Europe Genome Sequencing Market By Region, From 2020 to 2025 (USD Billion)
  8. Europe De Novo Sequencing Market By Region, From 2020 to 2025 (USD Billion)
  9. Europe Exome Sequencing Market By Region, From 2020 to 2025 (USD Billion)
  10. Europe RNA-Seq Market By Region, From 2020 to 2025 (USD Billion)
  11. Europe ChIP-Seq Market By Region, From 2020 to 2025 (USD Billion)
  12. Europe Methyl-Seq Market By Region, From 2020 to 2025 (USD Billion)
  13. Europe NGS Market By Application, From 2020 to 2025 (USD Billion)
  14. Europe Diagnostics Market By Region, From 2020 to 2025 (USD Billion)
  15. Europe Drug Discovery Market By Region, From 2020 to 2025 (USD Billion)
  16. Europe Biomarker Discovery Market By Region, From 2020 to 2025 (USD Billion)
  17. Europe Personalized Medicine Market By Region, From 2020 to 2025 (USD Billion)
  18. Europe Agriculture and Animals Research Market By Region, From 2020 to 2025 (USD Billion)
  19. U.K. NGS Market By Product, From 2020 to 2025 (USD Billion)
  20. U.K. NGS Market By Technology, From 2020 to 2025 (USD Billion)
  21. U.K. NGS Market By Application, From 2020 to 2025 (USD Billion)
  22. Germany NGS Market By Product, From 2020 to 2025 (USD Billion)
  23. Germany NGS Market By Technology, From 2020 to 2025 (USD Billion)
  24. Germany NGS Market By Application, From 2020 to 2025 (USD Billion)
  25. France NGS Market By Product, From 2020 to 2025 (USD Billion)
  26. France NGS Market By Technology, From 2020 to 2025 (USD Billion)
  27. France NGS Market By Application, From 2020 to 2025 (USD Billion)
  28. Italy NGS Market By Product, From 2020 to 2025 (USD Billion)
  29. Italy NGS Market By Technology, From 2020 to 2025 (USD Billion)
  30. Italy NGS Market By Application, From 2020 to 2025 (USD Billion)
  31. Spain NGS Market By Product, From 2020 to 2025 (USD Billion)
  32. Spain NGS Market By Technology, From 2020 to 2025 (USD Billion)
  33. Spain NGS Market By Application, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample